Prolyl oligopeptidase is a glyceraldehyde-3-phosphate dehydrogenase-binding protein that regulates genotoxic stress-induced cell death

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 4, 2013, Pages 850-857

  Matsuda, Takashi ^a   Sakaguchi, Minoru ^a   Tanaka, Satoshi ^a   Yoshimoto, Tadashi ^b   Takaoka, Masanori ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

Cell death; Cytosine arabinoside; Glyceraldehyde 3 phosphate dehydrogenase; NB 1 cells; Prolyl oligopeptidase

Indexed keywords

CYTARABINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROLYL ENDOPEPTIDASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CYTOPLASM; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; NEUROBLASTOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN LOCALIZATION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; CELL DEATH; CELL LINE, TUMOR; CELL NUCLEUS; CYTARABINE; DNA DAMAGE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SERINE ENDOPEPTIDASES;

EID: 84873699576     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.01.009     Document Type: Article

References (43)

1. G. Bellemère, P. Morain, H. Vaudry, and S. Jégou Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain Journal of Neurochemistry 84 2003 919 929
2. G. Bellemère, H. Vaudry, P. Morain, and S. Jegou Effect of prolyl endopeptidase inhibition on arginine-vasopressin and thyrotrophin-releasing hormone catabolism in the rat brain Journal of Neuroendocrinology 17 2005 306 313
3. I. Brandt, M. Gérard, K. Sergeant, B. Devreese, V. Baekelandt, and K. Augustyns Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein Peptides 29 2008 1472 1478
4. D.-M. Chuang, C. Hough, and V.V. Senatorov Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases Annual Review of Pharmacology and Toxicology 45 2005 269 290
5. A. Colell, D.R. Green, and J-E. Ricci Novel roles for GAPDH in cell death and carcinogenesis Cell Death and Differentiation 16 2009 1573 1581
6. D.F. Cunningham, and B. O'Connor Proline specific peptidases Biochimica et Biophysica Acta 1343 1997 160 186
7. E. Di Daniel, C.P. Glover, E. Grot, M.K. Chan, T.H. Sanderson, and J.H. White Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity Molecular and Cellular Neurosciences 41 2009 373 382
8. V. Fülöp, Z. Böcskei, and L. Polgár Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis Cell 94 1998 161 170
9. V. Fülöp, Z. Szeltner, and L. Polgár Catalysis of serine oligopeptidases is controlled by a gating filter mechanism EMBO Reports 1 2001 277 281
10. M. Fuxreiter, C. Magyar, T. Juhász, Z. Szeltner, L. Polgár, and I. Simon Flexibility of prolyl oligopeptidase: molecular dynamics and molecular framework analysis of the potential substrate pathways Proteins 60 2005 504 512
11. J.A. Garcia-Horsman, P.T. Männistö, and J.I. Venäläinen On the role of prolyl oligopeptidase in health and disease Neuropeptides 41 2007 1 24
12. D.A. Gewirtz A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochemical Pharmacology 57 1999 727 741
13. F. Goossens, I. De Meester, G. Vanhoof, and S. Scharpé Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids European Journal of Clinical Chemistry and Clinical Biochemistry 34 1996 17 22
14. M.R. Hara, N. Agrawal, S.F. Kim, M.B. Cascio, M. Fujimuro, and Y. Ozeki S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding Nature Cell Biology 7 2005 665 674
15. M.R. Hara, M.B. Cascio, and A. Sawa GAPDH as a sensor of NO stress Biochimica et Biophysica Acta 1762 2006 502 509
16. M.R. Hara, and S.H. Snyder Nitric oxide-GAPDH-Siah: a novel cell death cascade Cellular and Molecular Neurobiology 26 2006 527 538
17. R. Ishitani, M. Tanaka, K. Sunaga, N. Katsube, and D.M. Chuang Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis Molecular Pharmacology 53 1998 701 707
18. N. Katsube, K. Sunaga, H. Aishita, D.M. Chuang, and R. Ishitani ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons Journal of Pharmacology and Experimental Therapeutics 288 1999 6 13
19. H. Kumagai, and H. Sakai A porcine brain protein (35 K protein) which bundles microtubules and its identification as glyceraldehyde 3-phosphate dehydrogenase Journal of Biochemistry 93 1983 1259 1269
20. A.M. Lambeir Interaction of prolyl oligopeptidase with α-synuclein CNS & Neurological Disorders-Drug Targets 10 2011 349 354
21. P.T. Männisto, J. Venäläinen, A. Jalkanen, and J.A. García-Horsman Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders Drug News & Perspectives 20 2007 293 305
22. R. Mentlein Proline residues in the maturation and degradation of peptide hormones and neuropeptides FEBS Letters 234 1988 251 256
23. K. Meyer-Siegler, D.J. Mauro, G. Seal, J. Wurzer, J.K. deRiel, and M.A. Sirover A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase Proceedings of the National Academy of Sciences of the United States of America 88 1991 8460 8464
24. M.J. Moreno-Baylach, K.A. Puttonen, J. Tenorio-Laranga, J.I. Venäläinen, M. Storvik, and M.M. Forsberg Prolyl endopeptidase is involved in cellular signalling in human neuroblastoma SH-SY5Y cells Neurosignals 19 2011 97 109
25. T.T. Myöhänen, J. Tenorio-Laranga, B. Jokinen, R. Vazquez-Sanchz, M.J. Moreno-Baylach, and J.A. Garcia-Horsman Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner British Journal of Pharmacology 163 2011 1666 1678
26. T.T. Myöhänen, M.J. Hannula, R. Van Elzen, M. Gerard, P. Van Der Veken, and J.A. García-Horsman A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease British Journal of Pharmacology 166 2012 1097 1113
27. J. Park, D. Han, K. Kim, Y. Kang, and Y. Kim O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation Biochimica et Biophysica Acta 1794 2009 254 262
28. M.S. Phadke, N.F. Krynetskaia, A.K. Mishra, and E. Krynetskiy Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines Journal of Pharmacology and Experimental Therapeutics 331 2009 77 86
29. L. Polgár The prolyl oligopeptidase family Cellular and Molecular Life Sciences 59 2002 349 362
30. K.A. Puttonen, S. Lehtonen, A. Raasmaja, and P.T. Männistö A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3- phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine Toxicology in Vitro 20 2006 1446 1454
31. S. Roßner, I. Schulz, U. Zeitschel, R. Schliebs, V. Bigl, and H.U. Demuth Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer's disease Neurochemical Research 30 2005 695 702
32. M. Sakaguchi, T. Matsuda, E. Matsumura, T. Yoshimoto, and M. Takaoka Prolyl oligopeptidase participates in cell cycle progression in a human neuroblastoma cell line Biochemical and Biophysical Research Communications 409 2011 693 698
33. D. Sampath, V.A. Rao, and W. Plunkett Mechanisms of apoptosis induction by nucleoside analogs Oncogene 22 2003 9063 9074
34. P.A. Saunders, E. Chalecka-Franaszek, and D.M. Chuang Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis Journal of Neurochemistry 69 1997 1820 1828
35. J.S. Schneider, M. Giardiniere, and P. Morain Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys Neuropsychopharmacology 26 2002 176 182
36. I. Schulz, U. Zeitschel, T. Rudolph, D. Ruiz-Carrillo, J.U. Rahfeld, and B. Gerhartz Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion Journal of Neurochemistry 94 2005 970 979
37. R. Singh, and M.R. Green Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase Science 259 1991 365 368
38. M.A. Sirover New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochimica et Biophysica Acta 1432 1999 159 184
39. O. Söderberg, M. Gullberg, M. Jarvius, K. Ridderstråle, K.J. Leuchowius, and J. Jarvius Direct observation of individual endogenous protein complexes in situ by proximity ligation Nature Methods 3 2006 995 1000
40. O. Söderberg, K.J. Leuchowius, M. Gullberg, M. Jarvius, I. Weibrecht, and L.G. Larsson Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay Methods 45 2008 227 232
41. E.J. Tisdale Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway Journal of Biological Chemistry 276 2001 2480 2486
42. J.I. Venäläinen, R.O. Juvonen, and P.T. Männisto Evolutionary relationships of prolyl oligopeptidase family enzymes European Journal of Biochemistry 271 2004 2705 2715
43. T. Yoshimoto, K. Kado, F. Matsubara, N. Koriyama, H. Kaneto, and D. Tsuru Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect Journal of Pharmacobio-Dynamics 10 1987 730 735